ID

31404

Description

Interleukin-1 Receptor Antagonist and Insulin Sensitivity; ODM derived from: https://clinicaltrials.gov/show/NCT00928876

Link

https://clinicaltrials.gov/show/NCT00928876

Keywords

Versions (1)
  1. 8/19/18 8/19/18 -
Copyright Holder

see clinicaltrials.gov

Uploaded on

August 19, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Diabetes Mellitus, Type 2 NCT00928876

English

Eligibility Diabetes Mellitus, Type 2 NCT00928876

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult subjects with a bmi > 30 kg/m2
Description

Adult | Body mass index

Data type

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C1305855
3 or more characteristics of the metabolic syndrome
Description

Metabolic Syndrome X; Characteristics

Data type

boolean

Alias
UMLS CUI [1,1]
C0524620
UMLS CUI [1,2]
C1521970
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
inability to give informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
age < 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
known diabetes mellitus
Description

Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1]
C0011849
fasting plasma glucose > 7,0 mmol/l or hba1c > 6,2%
Description

Plasma fasting glucose measurement | Glycosylated hemoglobin A

Data type

boolean

Alias
UMLS CUI [1]
C0583513
UMLS CUI [2]
C0019018
presence of any medical condition that might interfere with the current study protocol
Description

Condition; Interferes with; Study Protocol

Data type

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0521102
UMLS CUI [1,3]
C2348563
immunodeficiency of immunosuppressive treatment
Description

Therapeutic immunosuppression; Immunologic Deficiency Syndromes

Data type

boolean

Alias
UMLS CUI [1,1]
C0021079
UMLS CUI [1,2]
C0021051
anti-inflammatory drugs (100 mg of aspirin/day is allowed)
Description

Anti-Inflammatory Agents | Aspirin

Data type

boolean

Alias
UMLS CUI [1]
C0003209
UMLS CUI [2]
C0004057
signs of current infection
Description

Infection; Current (present time)

Data type

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C0521116
history of recurrent infections
Description

Infection; Recurrent

Data type

boolean

Alias
UMLS CUI [1,1]
C3714514
UMLS CUI [1,2]
C2945760
pregnancy or breast feeding
Description

Pregnancy; Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
liver disease
Description

Liver diseases

Data type

boolean

Alias
UMLS CUI [1]
C0023895
renal disease
Description

Kidney Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0022658
neutropenia
Description

Neutropenia

Data type

boolean

Alias
UMLS CUI [1]
C0027947
Back to the top of the page

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT00928876

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Body mass index
Item
adult subjects with a bmi > 30 kg/m2
boolean
C0001675 (UMLS CUI [1])
C1305855 (UMLS CUI [2])
Metabolic Syndrome X; Characteristics
Item
3 or more characteristics of the metabolic syndrome
boolean
C0524620 (UMLS CUI [1,1])
C1521970 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Informed consent
Item
inability to give informed consent
boolean
C0021430 (UMLS CUI [1])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus
Item
known diabetes mellitus
boolean
C0011849 (UMLS CUI [1])
Plasma fasting glucose measurement | Glycosylated hemoglobin A
Item
fasting plasma glucose > 7,0 mmol/l or hba1c > 6,2%
boolean
C0583513 (UMLS CUI [1])
C0019018 (UMLS CUI [2])
Condition; Interferes with; Study Protocol
Item
presence of any medical condition that might interfere with the current study protocol
boolean
C0348080 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C2348563 (UMLS CUI [1,3])
Therapeutic immunosuppression; Immunologic Deficiency Syndromes
Item
immunodeficiency of immunosuppressive treatment
boolean
C0021079 (UMLS CUI [1,1])
C0021051 (UMLS CUI [1,2])
Anti-Inflammatory Agents | Aspirin
Item
anti-inflammatory drugs (100 mg of aspirin/day is allowed)
boolean
C0003209 (UMLS CUI [1])
C0004057 (UMLS CUI [2])
Infection; Current (present time)
Item
signs of current infection
boolean
C3714514 (UMLS CUI [1,1])
C0521116 (UMLS CUI [1,2])
Infection; Recurrent
Item
history of recurrent infections
boolean
C3714514 (UMLS CUI [1,1])
C2945760 (UMLS CUI [1,2])
Pregnancy; Breast Feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Liver diseases
Item
liver disease
boolean
C0023895 (UMLS CUI [1])
Kidney Diseases
Item
renal disease
boolean
C0022658 (UMLS CUI [1])
Neutropenia
Item
neutropenia
boolean
C0027947 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial